(Q38004480)

26 August 2017

1 reference

title

Serotonin in obsessions, compulsions, and the control of aggressive impulses (English)

1 reference

26 August 2017

0 references

Insel TR

1

1 reference

26 August 2017

Zohar J

series ordinal

2

1 reference

26 August 2017

Benkelfat C

series ordinal

3

1 reference

26 August 2017

Murphy DL

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

Annals of the New York Academy of Sciences

26 August 2017

published in

1 reference

26 August 2017

volume

600

1 reference

26 August 2017

page(s)

574-85; discussion 585-6

1 reference

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Fluoxetine in the treatment of obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Efficacy of trazodone as an anti obsessional agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Obsessive-compulsive disorder and serotonin: is there a connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

L-tryptophan in obsessive-compulsive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Different effects of 3-chlorophenylpiperazine on locomotor activity and acquisition of conditioned avoidance response in different strains of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Behavioral indications for serotonin receptor hypersensitivity in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Lactate infusions in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Effects of yohimbine in obsessive compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Biological markers in obsessive-compulsive and affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Aggression in humans correlates with cerebrospinal fluid amine metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Cerebrospinal fluid monoamine metabolite levels in male arsonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Acting out hostility in normal volunteers: negative correlation with levels of 5HIAA in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Correlations between aminergic metabolites simultaneously obtained from human CSF and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Cerebral glucose metabolic rates in obsessive compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

Difference in neurotransmitter metabolism in frontotemporal-lobe contusion and diffuse cerebral contusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16911.X

10.1111/J.1749-6632.1990.TB16911.X

21 January 2018

Identifiers

DOI

1 reference

release_4slgmbqgjngcbav3a4cjykgv5y

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4slgmbqgjngcbav3a4cjykgv5y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference